Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTime Finance Regulatory News (TIME)

Share Price Information for Time Finance (TIME)

Share Price is delayed by 15 minutes
Get Live Data
50.00    2.00 (4.17%)
Bid:
49.00
Ask:
51.00
Spread: 2.00 (4.082%)
Market Cap: £45.84m
TIME Live PriceLast checked at - London Stock Exchange

Intraday Time Finance Share Chart

Q3 Trading Update

24 Mar 2026 07:00

RNS Number : 7579X
Time Finance PLC
24 March 2026
 

 

 

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014 as amended by regulation 11 of the Market Abuse (Amendment) (EU Exit) Regulations 2019/310. Upon the publication of this announcement via Regulatory Information Service, this inside information is now considered to be in the public domain.

 

 

 

24 March 2026

Time Finance plc

(the "Group" or the "Company")

 

Q3 TRADING UPDATE

 

Record Lending Book and Record Nine-Month Revenues and Profits Before Tax

 

Time Finance plc, the AIM listed independent specialist finance provider, is pleased to provide a trading update for the nine-month period ended 28 February 2026 ("9M 2025/26"). The Group's strong performance in the first half of the current financial year has been maintained throughout the third quarter. Continued demand from UK businesses for the Group's multi-product funding offering has driven further growth in the gross lending book which stands at a record high of more than £236m at the end of February 2026. This is the nineteenth consecutive quarter of loan book growth for the Company.

 

Unaudited Nine Month 2025/26 Highlights

· Own-Book lending origination up 27% to £86.5m (9M 2024/25: £69.3m)

· Revenue up 4% to £28.3m (9M 2024/25: £27.3m)

· Profit before Tax up 5% to £6.2m (9M 2024/25: £5.9m)

· PBT margin improved by 100 bps to 22% (9M 2024/25: 21%)

· Net Tangible Assets up 13% to £48.5m at 28 February 2026 (28 February 2025: £43.0m)

· Gross lending-book up 12% to a record £236.4m at 28 February 2026 (28 February 2025: £210.2m)

· Deferred income up 10% to £29.1m at 28 February 2026 (28 February 2025: £26.4m), providing strong visibility of future earnings

· Net Arrears improved to 4.7% of the gross lending book at 28 February 2026 (28 February 2025: 5.3%)

· Net Bad Debt Write-Offs improved to 1.0% of the average lending book at 28 February 2026 (28 February 2025: 1.3%)

 

A key element of the Company's strategy is to focus on more secured lending. This is to be achieved primarily though the provision of Invoice Finance and the 'Hard' element of Asset Finance. These two core areas have accounted for 96% of new lending volume originated in the nine months of trading to 28 February 2026 (9M 2024/25: 91%), and now make up 88% of the total lending book (28 February 2025: 81%).

 

The continued positive trading momentum leads to the expectation that Group financial performance for the full year will be in line with market guidance.

 

Ed Rimmer, Chief Executive Officer commented:

"To be able to report all-time record nine-month Group Revenue and Profit Before Tax in what remain challenging macro-economic conditions is particularly pleasing. To have made these strides forward while maintaining robust credit criteria, as shown by the continued improvement in our arrears and our write-offs, is another key performance indicator that we feel underlines the robust nature of the business.

 

"As a result of all these factors, and as we near the end of the first year of our three-year growth strategy through to May 2028, the Board has confidence that the Group remains well placed to continue building long-term value for all our shareholders."

 

For more information and the chance to have your questions directly answered by the management team, please head to our interactive investor hub via: https://investors.timefinance.com/s/71ba43. Here you will find all company news and additional content to further explain Time Finance's strategy and developments.

 

Ends

 

 

For further information, please contact:

Time Finance plc

01225 474230

Ed Rimmer (CEO) / James Roberts (CFO)

ir@timefinance.com

Cavendish (NOMAD and Broker)

0207 220 0500

Ben Jeynes / Teddy Whiley (Corporate Finance)

Michael Johnson / Matt Lewis (Sales and ECM)

Walbrook PR

0207 933 8780

Nick Rome / Marcus Ulker

Timefinance@walbrookpr.com

 

 

Subscribe to our news alert service: https://investors.timefinance.com/auth/signup

 

About Time Finance:

Time Finance's purpose is to help UK businesses thrive and survive through the provision of flexible funding facilities. It offers a multi-product range for SMEs primarily concentrating on Asset Finance, Invoice Finance and Secured Loans. While focused on being an 'own-book' lender, the Group does retain the ability to broke-on deals where appropriate, enabling it to optimize business levels through market and economic cycles.

 

More information is available on the Company website, www.timefinance.com, and the interactive investor hub, https://investors.timefinance.com

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTFLFSRVFIVFIR
Date   Source Headline
23rd Apr 20077:02 amRNSStrategic Partnership
2nd Apr 20075:27 pmRNSTotal Voting Rights
2nd Apr 20075:22 pmRNSAdditional Listing
8th Mar 20077:04 amRNSPackaging Partnership
7th Mar 20073:32 pmRNSDirectorate Change
7th Mar 20073:28 pmRNSAdditional Listing
5th Mar 20077:00 amRNSPatent Update
28th Feb 20075:22 pmRNSTotal Voting Rights
19th Feb 20077:01 amRNSAppointment of Distributor
15th Feb 20074:36 pmRNSAdditional Listing
12th Feb 20077:01 amRNSNew Strategic Partnership
8th Feb 20077:02 amRNSiStrip Progress
5th Feb 20074:55 pmRNSAdditional Listing
2nd Feb 20077:00 amRNSStrategic Partnership
2nd Feb 20077:00 amRNSTrading Statement
15th Jan 20076:17 pmRNSAdditional Listing
28th Dec 20067:00 amRNSTotal Voting Rights
19th Dec 20065:57 pmRNSAdditional Listing
20th Oct 20065:30 pmRNSAdditional Listing
18th Sep 20068:46 amRNSNew Technology
18th Sep 20068:45 amRNSInterim Results
4th Sep 20062:55 pmRNSAdditional Listing
25th Jul 20062:58 pmRNSAdditional Listing
29th Jun 200610:18 amRNSResult of AGM
12th Jun 20063:46 pmRNSAnnual Report and Accounts
5th Jun 200612:11 pmRNSAdditional Listing
31st May 200612:29 pmRNSAdditional Listing
16th May 20062:59 pmRNSAdditional Listing
11th May 20067:01 amRNSFinal Results
9th May 20063:16 pmRNSAdditional Listing
5th May 20067:00 amRNSNestle adopts technology
28th Mar 200610:31 amRNSNotice of Exercise of Warrant
28th Mar 200610:24 amRNSAdditional Listing
28th Mar 200610:21 amRNSAdditional Listing
10th Mar 20062:12 pmRNSAdditional Listing
13th Feb 20068:00 amRNSChange of Adviser
10th Feb 20065:35 pmPRNShareholding
9th Feb 20067:00 amPRNTechnology Breakthrough
3rd Feb 20067:00 amPRNEuropean Contract Win
10th Jan 200610:00 amPRNHolding(s) in Company
6th Dec 20054:00 pmPRNExercise of Warrants and Convertible Loan Stock
18th Nov 20057:00 amPRNTrading Update
9th Nov 20052:59 pmPRNSignificant Shareholdings
1st Nov 200510:08 amPRNIssue of New Shares
11th Oct 20056:00 amPRNPlacing
28th Sep 20059:28 amPRNSignificant Shareholding
23rd Sep 20056:00 amPRNInterim Results
16th Aug 20054:03 pmPRNChange of Adviser
30th Jun 20051:55 pmPRNFinal Results
18th Apr 20056:00 amPRNLaunch with Crown

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.